PRICE T ROWE ASSOCIATES INC /MD/ - AKERO THERAPEUTICS INC ownership

AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 157 filers reported holding AKERO THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.70 and the average weighting 0.5%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of AKERO THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$192,721
+25.5%
3,810,194
+15.8%
0.03%
+33.3%
Q2 2023$153,595
+53.0%
3,289,643
+25.4%
0.02%
+40.0%
Q1 2023$100,383
-23.7%
2,623,680
+9.3%
0.02%
-28.6%
Q4 2022$131,577
-99.7%
2,401,037
+64.2%
0.02%
+162.5%
Q3 2022$49,797,000
+1057.3%
1,462,424
+221.2%
0.01%
+700.0%
Q2 2022$4,303,000
-33.4%
455,302
-0.0%
0.00%0.0%
Q1 2022$6,462,000
-73.7%
455,364
-60.7%
0.00%
-50.0%
Q4 2021$24,524,000
-4.7%
1,159,530
+0.7%
0.00%0.0%
Q3 2021$25,738,000
-10.1%
1,151,599
-0.2%
0.00%
-33.3%
Q2 2021$28,636,000
+10.5%
1,154,203
+29.2%
0.00%0.0%
Q1 2021$25,910,000
+52.8%
893,146
+35.8%
0.00%
+50.0%
Q4 2020$16,962,000
+9.6%
657,455
+30.8%
0.00%0.0%
Q3 2020$15,471,000
+323.6%
502,481
+242.9%
0.00%
Q2 2020$3,652,000
-28.1%
146,532
-38.8%
0.00%
-100.0%
Q1 2020$5,077,000
+1.0%
239,478
+5.8%
0.00%0.0%
Q4 2019$5,025,000
+8.3%
226,399
+11.0%
0.00%0.0%
Q3 2019$4,639,000
+20.2%
203,913
+1.2%
0.00%0.0%
Q2 2019$3,859,000201,5000.00%
Other shareholders
AKERO THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Skorpios Trust 3,271,829$125,180,17850.58%
COMMODORE CAPITAL LP 790,000$30,225,4004.60%
Redmile Group, LLC 2,044,389$78,218,3233.39%
SILVERARC CAPITAL MANAGEMENT, LLC 202,561$7,749,9843.20%
Ghost Tree Capital, LLC 275,000$10,522,0003.11%
Avidity Partners Management LP 2,447,000$93,622,2203.11%
Atlas Venture Life Science Advisors, LLC 594,251$22,736,0433.08%
Logos Global Management LP 400,000$15,304,0002.19%
Yiheng Capital Management, L.P. 1,125,791$43,072,7641.70%
Boxer Capital, LLC 831,495$31,8131.56%
View complete list of AKERO THERAPEUTICS INC shareholders